PLEASANTON, CA--(Marketwired - Oct 22, 2014) - ZELTIQ ® (
Event: Barclays MedTech SMID Cap Growth Conference Format: One-on-One Meetings Only Date: Monday, November 3, 2014
Event: Stifel Healthcare Conference 2014 Format: Presentation and One-on-One Meetings Date: Wednesday, November 19, 2014 Time: 10:55 a.m. ET / 7:55 a.m. PT
Event: Goldman Sachs US Emerging / SMID Cap Growth Conference Format: Presentation and One-on-One Meetings Date: Thursday, November 20, 2014 Time: 3:40 p.m. ET / 12:40 p.m. PT
Event: Canaccord Genuity Medical Technology & Diagnostics Forum Format: Presentation and One-on-One Meetings Date: Thursday, November 20, 2014 Time: 11:30 a.m. ET / 8:30 a.m. PT
Audio webcasts of the Company's presentations will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com . Replays of the presentations will be available for 90 days.
About ZELTIQ ® Aesthetics, Inc. ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting ® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.